Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Participant Database for Autism Research Studies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00549731
Recruitment Status : Recruiting
First Posted : October 26, 2007
Last Update Posted : September 18, 2020
Sponsor:
Collaborators:
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Tal Kenet, Massachusetts General Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Condition or disease
Autism Spectrum Disorder

Detailed Description:

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 120 participants
Observational Model: Other
Time Perspective: Other
Official Title: Database for Persons Interested in Research Studies of Developmental Disorders
Actual Study Start Date : June 2013
Estimated Primary Completion Date : June 2023
Estimated Study Completion Date : June 2023

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Healthy individuals

No intervention

Healthy participants ages 14-32 for a neuroimaging study.
Individuals with Autism Spectrum Disorder

No intervention

ASD participants ages 14-32 for a neuroimaging study.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 32 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adult/Pediatric
Criteria

Inclusion Criteria:

  • Typically-developing, healthy adolescents and adults (ages 14-32)
  • Adolescents and adults with autism spectrum disorder (ages 14-32)

Exclusion Criteria:

  • Extreme premature birth (<34 weeks)
  • Known genetic disorders related to autism (e.g. Fragile X)
  • Recent diagnosis of psychosis (within 6 months)
  • Some other psychiatric diagnoses may be excluded following screening (e.g. Tourette's syndrome).
  • Metal implants / permanent retainers / hair dyes with metallic components
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00549731


Contacts
Layout table for location contacts
Contact: Nicole McGuiggan, Rsch Coord 617-966-9766 TRANSCEND@partners.org

Locations
Layout table for location information
United States, Massachusetts
Martinos Center of Biomedical Imaging Recruiting
Charlestown, Massachusetts, United States, 02129
Sponsors and Collaborators
Massachusetts General Hospital
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
Investigators
Layout table for investigator information
Principal Investigator: Tal Kenet, Ph.D Massachusetts General Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Tal Kenet, Associate Professor, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00549731    
Other Study ID Numbers: 2007-P-000062
5R01MH117998 ( U.S. NIH Grant/Contract )
First Posted: October 26, 2007    Key Record Dates
Last Update Posted: September 18, 2020
Last Verified: September 2020
Keywords provided by Tal Kenet, Massachusetts General Hospital:
autism
autistic
language
 development
developmental
assessment
Additional relevant MeSH terms:
Layout table for MeSH terms
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders